Immunogenicity and reactogenicity of heterologous COVID-19 vaccination in pregnant women

This open-labeled non-inferiority trial evaluated immunogenicity and reactogenicity of heterologous and homologous COVID-19 vaccination schedules in pregnant Thai women. 18–45-year-old pregnant women with no history of COVID-19 infection or vaccination and a gestational age of ≥12 weeks were randomi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chayachinda, Chenchit, Watananirun, Kanokwaroon, Phatihattakorn, Chayawat, Anuwutnavin, Sanitra, Niyomnaitham, Suvimol, Phongsamart, Wanatpreeya, Lapphra, Keswadee, Wittawatmongkol, Orasri, Rungmaitree, Supattra, Jansarikit, Laddawan, Boonnak, Kobporn, Wongprompitak, Patimaporn, Senawong, Sansnee, Upadhya, Avishek, Toh, Zheng Quan, Licciardi, Paul V., Chokephaibulkit, Kulkanya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Coronavirus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406153/
https://www.ncbi.nlm.nih.gov/pubmed/37439770
http://dx.doi.org/10.1080/21645515.2023.2228670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406153/
https://www.ncbi.nlm.nih.gov/pubmed/37439770
http://dx.doi.org/10.1080/21645515.2023.2228670

Ejemplares similares